What's New In Investments, Funds? - Waverton, Avista Capital

Editorial Staff

3 March 2021

Waverton Investment Management
, a New York-based healthcare private equity firm, has held the final closing of Avista Capital Partners V, and its offshore version, Avista Capital Partners (Offshore) V. Fundraising beat the firm’s $775 million target, closing with $1.2 billion in committed capital.

Fund V has a diversified set of investors, including public pension funds, university endowments and foundations, family offices, insurance companies and asset managers across North America, Europe, Asia and the Middle East.

“The rising global demand for healthcare products and services will continue to present a host of compelling investment opportunities where our sector expertise can drive value creation and generate strong outcomes for our investors,” Thompson Dean and David Burgstahler, managing partners and co-chief executives at Avista, said.

UBS acted as placement agent and Kirkland & Ellis provided legal counsel for Avista.

Avista Capital Partners was founded in 2005 and has invested more than $6 billion in more than 35 healthcare-related businesses worldwide.